Monographie - Moxifloxacin

Dernière mise à jour :
19/11/2024

Moxifloxacin

Structure chimique

Noms commerciaux

Les noms commerciaux sont donnés à titre indicatif et la composition en excipients peut être différente selon les pays et selon les laboratoires

Actira	Espagne, Luxembourg, Pays bas, Suède
Avalox	Allemagne, Arabie Saoudite, Argentine, Australie, Belgique, Brésil, Canada, Chili, Colombie, Danemark, Emirats Arabes Unis , Equateur, Etats Unis d’Amérique, Finlande, Hongrie, Irlande, Malaisie, Maroc, Mexique, Nouvelle Zélande, Pays bas, Pérou, Roumanie, Suède, Turquie, Vénézuela
Axokine	Vénézuela
Mahaflox	Inde
Mofelox	Turquie
Mofinacin	Roumanie
Moflaxa	Roumanie
Moksefen	Turquie
Moksilox	Turquie
Moxacin	Turquie
Moxifix	Turquie
Moxifloxin	Allemagne, Belgique
Moxifloxina	Roumanie
Moxifloxino	Chili, Espagne
Muzdil	Espagne
Octegra	Pays bas, Suède
Pixiriv	Mexique
Praiva	Equateur, Pérou
Proflox	Luxembourg

Bibliographie : Moxifloxacin

	Type	Source
2017	Revue	Barker B, Feddema S, Rusho WJ, Dengg R. Visual compatibility of vasopressin with other injectable drugs. Am J Health-Syst Pharm 2005 ; 62: 1969-1976.
2145	Revue	Fernandez-Varon E, Marin P, Espuny A, Villamayor L, Escudero E, Carceles C. Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36%® and Dianeal PD1 3.86%®). J Clin Pharm Ther 2006 ; 31: 641-643.
2231	Revue	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2262	Revue	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2269	Revue	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3109	Laboratoire	Moxifloxacine (Izilox®) -Notice information Bayer Schering Pharma 2010
3162	Laboratoire	Moxifloxacine (Izilox®) - Résumé des caractéristiques du produits Bayer HealthCare 2010
3249	Revue	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3385	Revue	Raverdi V, Ampe E, Hecq JD, Tulkens PM. Stability and compatibility of vancomycin for administration by continuous infusion. J Antimicrob Chemother 2013 ; 68: 1179-1182.
3865	Revue	Vicky M, Samit S, Jaymin P, Michael C T. Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration. Int J Pharm Compound 2016 ; 20, 3 : 236-238.
4650	Laboratoire	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021
4758	Revue	Schmidt J.P, Steppe M. Stability Study and Simultaneous Determination of Norepinephrine, Moxifloxacin, and Piperacillin + Tazobactam Mixtures Applied in Intensive Care Medicine . Curr Pharm Anal 2023 ; 19, 4: 307-316.

Mentions Légales